Hims & Hers Health Inc.’s recently made public that its Chief Legal Officer Boughton Soleil unloaded Company’s shares for reported $24620.0 on Oct 18. In the deal valued at $4.44 per share,5,545 shares were sold. As a result of this transaction, Boughton Soleil now holds 330,271 shares worth roughly $ 1.4 million.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Then, Boughton Soleil sold 4,785 shares, generating $21,198 in total proceeds. Upon selling the shares at $4.43, the Chief Legal Officer now owns 335,816 shares.
Before that, Boughton Soleil sold 22,003 shares. Hims & Hers Health Inc. shares valued at $110,895 were divested by the Chief Legal Officer at a price of $5.04 per share. As a result of the transaction, Boughton Soleil now holds 340,601 shares, worth roughly $1.45 million.
Piper Sandler downgraded its Hims & Hers Health Inc. [HIMS] rating to a Neutral from a an Overweight in a research note published On Friday, October 17, 2022; the price target was decreased to $6 from $8. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in early September with a ‘”a Hold”‘ rating. SVB Leerink began covering HIMS with “an Underperform” recommendation on July 15, 2022. Guggenheim started covering the stock on April 14, 2022. It rated HIMS as “a Buy”.
Price Performance Review of HIMS
On Friday, Hims & Hers Health Inc. [NYSE:HIMS] saw its stock jump 1.19% to $4.25. Over the last five days, the stock has lost -5.35%. Hims & Hers Health Inc. shares have fallen nearly -35.11% since the year began. Nevertheless, the stocks have fallen -49.04% over the past one year. While a 52-week high of $9.19 was reached on 08/15/22, a 52-week low of $2.72 was recorded on 05/12/22. SMA at 50 days reached $5.34, while 200 days put it at $5.01. A total of 1.57 million shares were traded, compared to the trading of 1.31 million shares in the previous session.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 4.11, which if violated will result in even more drops to 3.97. On the upside, there is a resistance level at 4.34. A further resistance level may holdings at 4.43. The Relative Strength Index (RSI) on the 14-day chart is 35.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.22%. Stochastics %K at 29.26% indicates the stock is a holding.
How much short interest is there in Hims & Hers Health Inc.?
A steep rise in short interest was recorded in Hims & Hers Health Inc. stocks on Jul 14, 2022, growing by 3.03 million shares to a total of 12.31 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 9.28 million shares. There was a rise of 24.61%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 10.22% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.44.
Hims & Hers Health Inc. [HIMS] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 10,938,001 shares, or roughly 5.50% of the outstanding HIMS shares. In other words, the investor’s shares have risen by 1,937,761 from its previous 13-F filing of 9000240.0. Additionally, BlackRock Fund Advisors increased 250.80% of its stake after which the total value it holdings stand at $42,172,295. Over the last quarter, SSgA Funds Management, Inc. purchased 1,549,546 shares of Hims & Hers Health Inc., while Marshall Wace LLP bought 1,085,736 shares. At present, Geode Capital Management LLC is holding 2,086,202 shares valued at $11.64 million. Renaissance Technologies LLC owned 1,959,100 shares of the company at the time of its most recent 13F filing, worth $10.93 million.
According to FactSet, Hims & Hers Health Inc.’s share price will average $7.61 in the next year, based on opinions of analysts polled by the firm. This is up nearly 78.57 percent from its previous closing price of $4.20. Analysts expect Hims & Hers Health Inc. stock to reach the higher price of $12.00, while the lowest price estimate is $5.00. However, 9 analysts have rated HIMS stock as a Hold in their predictions for 2022.